MetaCap

Acadia Healthcare (ACHC) vs Fortrea (FTRE)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Fortrea (FTRE) has outperformed Acadia Healthcare (ACHC) over the past year, gaining 120.8% versus a gain of 7.3%. Acadia Healthcare is the larger company by market cap ($2.65 billion vs $1.94 billion), about 1.4 times the size. On valuation, Acadia Healthcare trades at a lower forward P/E (15.4x vs 17.8x for Fortrea).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ACHC+7.34%FTRE+120.84%
+136%+35%-66%
Oct 7, 20251 yearOct 7, 2026
ACHC-60.04%FTRE-31.69%
+39%-27%-93%
Jun 12, 20235 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ACHC versus FTRE key metrics
MetricACHCFTRE
Share price$28.48$20.37
Market cap$2.65B$1.94B
1-day change-2.57%-0.92%
YTD return+105.99%+19.19%
1-year return+7.34%+120.84%
5-year return-48.62%—
Forward P/E15.4217.79
EPS (TTM)$-12.42$-0.91
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$3.31B—
Revenue growth (YoY)+5.04%—
Net income (latest FY)$-1.10B—
Net margin-33.29%—
52-week high$35.83$23.51
52-week low$11.43$8.55
Distance from 52-week high-20.51%-13.36%
Analyst consensusbuybuy
Avg. price target upside+18.64%+2.26%
Average volume2.04M1.47M
Shares outstanding93.10M95.10M
Employees25,00014,000
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • FTRE has outperformed ACHC by 113.5 percentage points over the past year.

About Acadia Healthcare

ACHC stock →

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico.

Health Care · Medical Specialities · 25,000 employees

About Fortrea

FTRE stock →

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services.

Health Care · Medical Specialities · 14,000 employees

ACHC vs FTRE FAQ

Which is bigger, Acadia Healthcare or Fortrea?

Acadia Healthcare (ACHC) is larger, with a market capitalization of $2.65B compared with $1.94B for Fortrea (FTRE).

Which stock has performed better over the past year, ACHC or FTRE?

FTRE returned +120.84% over the past 12 months, compared with +7.34% for ACHC (price return, excluding dividends). Past performance does not predict future results.

Are Acadia Healthcare and Fortrea in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons